Cargando…
The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study
BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598970/ https://www.ncbi.nlm.nih.gov/pubmed/26449867 http://dx.doi.org/10.1186/s12885-015-1670-6 |
_version_ | 1782394165134360576 |
---|---|
author | Jaillardon, Laetitia Abadie, Jérome Godard, Tiffanie Campone, Mario Loussouarn, Delphine Siliart, Brigitte Nguyen, Frédérique |
author_facet | Jaillardon, Laetitia Abadie, Jérome Godard, Tiffanie Campone, Mario Loussouarn, Delphine Siliart, Brigitte Nguyen, Frédérique |
author_sort | Jaillardon, Laetitia |
collection | PubMed |
description | BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant for investigating new therapeutic pathways. Insulin-like growth factor Type-1 receptor (IGF1R) is frequently overexpressed in primary human breast cancers, with a growing role in the TN phenotype. The purpose of this study was to investigate the Dog as a candidate model for IGF1R-overexpressing mammary carcinoma. METHODS: 150 bitches with canine mammary carcinoma (CMC) and a known 2-year follow-up were retrospectively included. IGF1R expression was assessed by immunohistochemistry (IHC) using a similar scoring system as for HER2 in breast cancer. The prognostic value of the IGF1R expression was assessed in terms of overall and specific survival as well as disease-free interval (DFI). RESULTS: 47 CMC (31 %) were classified as luminal and 103 (69 %) as triple-negative (TN-CMC). 41 % of CMC overexpressed IGF1R (IHC score 3+) of which 76 % were TN-CMC and 62 % grade III. IGF1R overexpression was associated with aggressive features including lymphovascular invasion, histological grade III, low ER expression and the TN phenotype. Univariate and multivariate analyses revealed that IGF1R overexpression was associated with shorter overall and specific survivals and shorter DFI in TN-CMC. CONCLUSIONS: IGF1R overexpression is common and related to a poor outcome in canine invasive mammary carcinoma, particularly in the triple negative subtype, as in human breast cancer. Preclinical studies using the Dog as a spontaneous animal model could be considered to investigate new therapies targeting IGF1R in triple-negative breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1670-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4598970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45989702015-10-09 The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study Jaillardon, Laetitia Abadie, Jérome Godard, Tiffanie Campone, Mario Loussouarn, Delphine Siliart, Brigitte Nguyen, Frédérique BMC Cancer Research Article BACKGROUND: Dogs spontaneously develop invasive mammary carcinoma with a high prevalence of the triple-negative (TN) subtype (lack of ER-Estrogen Receptor and PR-Progesterone Receptor expression, lack of HER2-Human Epidermal Growth Factor Receptor 2 overexpression), making this animal model relevant for investigating new therapeutic pathways. Insulin-like growth factor Type-1 receptor (IGF1R) is frequently overexpressed in primary human breast cancers, with a growing role in the TN phenotype. The purpose of this study was to investigate the Dog as a candidate model for IGF1R-overexpressing mammary carcinoma. METHODS: 150 bitches with canine mammary carcinoma (CMC) and a known 2-year follow-up were retrospectively included. IGF1R expression was assessed by immunohistochemistry (IHC) using a similar scoring system as for HER2 in breast cancer. The prognostic value of the IGF1R expression was assessed in terms of overall and specific survival as well as disease-free interval (DFI). RESULTS: 47 CMC (31 %) were classified as luminal and 103 (69 %) as triple-negative (TN-CMC). 41 % of CMC overexpressed IGF1R (IHC score 3+) of which 76 % were TN-CMC and 62 % grade III. IGF1R overexpression was associated with aggressive features including lymphovascular invasion, histological grade III, low ER expression and the TN phenotype. Univariate and multivariate analyses revealed that IGF1R overexpression was associated with shorter overall and specific survivals and shorter DFI in TN-CMC. CONCLUSIONS: IGF1R overexpression is common and related to a poor outcome in canine invasive mammary carcinoma, particularly in the triple negative subtype, as in human breast cancer. Preclinical studies using the Dog as a spontaneous animal model could be considered to investigate new therapies targeting IGF1R in triple-negative breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1670-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-08 /pmc/articles/PMC4598970/ /pubmed/26449867 http://dx.doi.org/10.1186/s12885-015-1670-6 Text en © Jaillardon et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jaillardon, Laetitia Abadie, Jérome Godard, Tiffanie Campone, Mario Loussouarn, Delphine Siliart, Brigitte Nguyen, Frédérique The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title | The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title_full | The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title_fullStr | The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title_full_unstemmed | The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title_short | The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
title_sort | dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598970/ https://www.ncbi.nlm.nih.gov/pubmed/26449867 http://dx.doi.org/10.1186/s12885-015-1670-6 |
work_keys_str_mv | AT jaillardonlaetitia thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT abadiejerome thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT godardtiffanie thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT camponemario thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT loussouarndelphine thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT siliartbrigitte thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT nguyenfrederique thedogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT jaillardonlaetitia dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT abadiejerome dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT godardtiffanie dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT camponemario dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT loussouarndelphine dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT siliartbrigitte dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy AT nguyenfrederique dogasanaturallyoccurringmodelforinsulinlikegrowthfactortype1receptoroverexpressingbreastcanceranobservationalcohortstudy |